Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (246)	8/5/2011 6:47:05 PM
From: BulbaMan	Read Replies (1) \| Respond to of 400

8/5/11 Contest Update Apparently, the shady crew that raised the debt ceiling were lousy engineers. And the compromised ceiling quickly collapsed on the heads of investors, leaving many senseless. Now if only they had listened to the Tea Party experts and left the ceiling alone, stocks would have gone through the roof. ;-) Gored by Dendreon, biotech stocks were especially wounded. And at Friday’s close, the Nasdaq Biotech Index was down -3.13% YTD (vs. up 11.38% YTD a week ago) and the Contest median was down -8.30% YTD (vs. up 10.44% YTD a week ago). The Nasdaq Composite Index was down -4.54% YTD (vs. up 3.90% YTD a week ago). A large position in ICGN, steadied by Pfizer’s buyout price, limited losses for GENE’s portfolio (up 46.93 % YTD), which remained in the lead. MCBIO’s portfolio (up 33.16% YTD) held on to second place while, just a smidgen behind, JIBAC’s portflio (up 33.11% YTD) moved into third place. At Friday's close, a mere 12 (vs. 29 last week) of the 38 Contest portfolios were in the black, while 15 of the 38 were beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables). Portfolio adjustments: None It’s only money, so relax and enjoy the weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 8/5/11 Rank Name Profit/Loss 1 GENE 46,933 2 MCBIO 33,158 3 JIBAC 33,107 4 ROCKY 26,222 5 RKRW 18,835 6 JULIUS 15,794 7 FIB 13,555 8 RRGE 9,928 9 GHMM 8,564 10 IJF 3,913 Week's Top 5 Gainers Symbol 7/29 8/5 % change MRNA 0.21 0.24 14.29% NRGX.OB 0.57 0.65 14.04% AKRX 6.93 7.44 7.36% AMAG 14.81 15.82 6.82% ARRY 2.12 2.15 1.42% Week's Top 5 Losers Symbol 7/29 8/5 % change DNDN 36.90 12.56 -65.96% PACB 11.01 6.50 -40.96% SVNT 7.00 4.39 -37.29% GNOM 12.39 8.41 -32.12% ZLCS 2.30 1.61 -30.00%